AnaptysBio, Inc. | TalkMarkets

Latest Posts

About This Stock More About This Stock

Last Week's Notable Insider Buys: Beacon Roofing, Chipotle, IPOs, Latham And More

Article By: Benzinga

Sunday, May 2, 2021 12:17 PM EDT

Here are some of the most noteworthy insider purchases that were reported in the past week.

In this article: CLI, CMG, BECN, RAIN, ANAB, TELL, SWIM, IMPL, KNBE, AMEH

Read

AnaptysBio Price Target Raised To $145 From $101 At Jefferies

Article By: The Fly

Monday, February 19, 2018 2:20 PM EDT

Jefferies analyst Biren Amin raised his price target for AnaptysBio to $145 after the company presented final data from its Phase IIa trial of ANB020 in 12 mod-to-severe adult atopic dermatitis patients.

In this article: ANAB Also: SNY, REGN

Read

5 Best Performing IPOs Of 2017

Article By: Zacks Investment Research

Friday, December 29, 2017 6:28 PM EDT

2017 marked a bounce back for the U.S. IPO market courtesy of improving economic fundamentals and consumer sentiment. Successful IPOs poured in primarily from the biotech and technology sectors and featured the comeback of Chinese issuers.

In this article: URGN, ANAB, SGH, CLXT, ROKU, SNAP, APRN

Read

4 Biotech Stocks Ready To Crush The Market In 2018

Article By: Zacks Investment Research

Wednesday, December 27, 2017 7:51 PM EDT

The year 2017 has been quite impressive one for the biotech sector as evident from the 19.4% gain registered so far by the Nasdaq Biotechnology Index. This is surely welcome news for investors since the industry suffered a decline of 19.2% last year.

In this article: SBMFF, ACAD, SGMO, ANAB Also: CELG, GILD

Read